Core Viewpoint - The company held its third board meeting on December 26, 2025, where several important resolutions were passed, including adjustments to fundraising projects, the addition of implementation entities, and the establishment of a high-level compensation system [1] Group 1: Fundraising Project Adjustments - The board approved a proposal to extend the construction period for the "Information System Upgrade Project" and the "Medical Consumables Centralized Operation Service Project," optimizing the internal investment structure to enhance fundraising efficiency [2] - The addition of an implementation entity for the "Medical Consumables Centralized Operation Service Project" was also approved, pending shareholder meeting review [2][6] Group 2: Fundraising Replacement and Compliance - The board approved a proposal to use raised funds to replace previously invested self-raised funds for fundraising projects and issuance costs, which complies with regulatory requirements and does not affect the normal implementation of fundraising projects [4] - The accounting firm provided a verification report, and the sponsor also issued a no-objection opinion regarding this replacement [4][3] Group 3: Governance Structure and Management Optimization - The board approved the establishment of a "Director and Senior Management Compensation Management System," which will be submitted for shareholder meeting review [5] - A proposal to adjust the company's organizational structure for 2026 was also approved to further optimize the management system [5] Group 4: Upcoming Shareholder Meeting - The board decided to hold the first temporary shareholder meeting of 2026 on January 13, 2026, to submit the aforementioned proposals for shareholder voting [6] - The series of resolutions passed by the board reflects the company's emphasis on the standardized use of raised funds and strategic development, which will help optimize resource allocation and enhance core competitiveness [6]
建发致新董事会通过多项议案 涉及募投项目调整及组织架构优化